HIF1A and ductal breast carcinoma in situ: In the BRCA1 mutation-related cases with DCIS and concomitant invasive cancer (N = 29), the frequency of HIF-1α overexpression was high in both lesions: 62% (18/29) and 83% (24/29), respectively (p = 0.264;Table 3).